Significance of Anti-angiogenic agents
Anti-angiogenic agents are substances that inhibit the angiogenesis process, which is essential for tumor growth. These agents, like bevacizumab, have demonstrated effectiveness in treating metastatic breast cancer by preventing the formation of new blood vessels. By targeting the creation of blood vessels, anti-angiogenic agents can limit tumor growth and spread by cutting off their nutrient supply. Many of these therapies are currently undergoing clinical trials to further assess their potential in cancer treatment.
Synonyms: Anti-angiogenesis drugs, Vegf inhibitors
The below excerpts are indicatory and do represent direct quotations or translations. It is your responsibility to fact check each reference.
The concept of Anti-angiogenic agents in scientific sources
Anti-angiogenic agents, like bevacizumab, hinder the angiogenesis process vital for tumor growth, demonstrating effectiveness particularly in treating metastatic breast cancer, according to regional sources.
From: The Malaysian Journal of Medical Sciences
(1) Medications that inhibit the growth of new blood vessels, often used in cancer treatment to starve tumours of the nutrients they need to grow.[1]